C120H150N40O7 — CID 158431567
(3S)-3-[(1S)-2-[5-(6-amino-3-pyridinyl)-2-pyridinyl]-1-(2H-tetrazol-5-yl)ethyl]hexan-2-one;(3S)-3-[(1S)-2-[6-(2,5-dihydro-1H-pyrrol-3-yl)-3-pyridinyl]-1-(2H-tetrazol-5-yl)ethyl]hexan-2-one;(3S)-3-[(1S)-2-[6-[2-(dimethylamino)pyrimidin-5-yl]-3-pyridinyl]-1-(2H-tetrazol-5-yl)ethyl]hexan-2-one;(3S)-3-[(1S)-2-[5-[4-(3-hydroxyazetidin-3-yl)phenyl]-2-pyridinyl]-1-(2H-tetrazol-5-yl)ethyl]hexan-2-one;(3S)-3-[(1S)-2-[5-(1H-indazol-5-yl)-2-pyridinyl]-1-(2H-tetrazol-5-yl)ethyl]hexan-2-one;(3S)-3-[(1S)-2-[5-(1,2,3,6-tetrahydropyridin-4-yl)-2-pyridinyl]-1-(2H-tetrazol-5-yl)ethyl]hexan-2-one (PubChem CID 158431567) has the molecular formula C120H150N40O7 and a molecular weight of 2264.79 g/mol. Its IUPAC name is (3S)-3-[(1S)-2-[5-(6-amino-3-pyridinyl)-2-pyridinyl]-1-(2H-tetrazol-5-yl)ethyl]hexan-2-one;(3S)-3-[(1S)-2-[6-(2,5-dihydro-1H-pyrrol-3-yl)-3-pyridinyl]-1-(2H-tetrazol-5-yl)ethyl]hexan-2-one;(3S)-3-[(1S)-2-[6-[2-(dimethylamino)pyrimidin-5-yl]-3-pyridinyl]-1-(2H-tetrazol-5-yl)ethyl]hexan-2-one;(3S)-3-[(1S)-2-[5-[4-(3-hydroxyazetidin-3-yl)phenyl]-2-pyridinyl]-1-(2H-tetrazol-5-yl)ethyl]hexan-2-one;(3S)-3-[(1S)-2-[5-(1H-indazol-5-yl)-2-pyridinyl]-1-(2H-tetrazol-5-yl)ethyl]hexan-2-one;(3S)-3-[(1S)-2-[5-(1,2,3,6-tetrahydropyridin-4-yl)-2-pyridinyl]-1-(2H-tetrazol-5-yl)ethyl]hexan-2-one.
| Compound Name | (3S)-3-[(1S)-2-[5-(6-amino-3-pyridinyl)-2-pyridinyl]-1-(2H-tetrazol-5-yl)ethyl]hexan-2-one;(3S)-3-[(1S)-2-[6-(2,5-dihydro-1H-pyrrol-3-yl)-3-pyridinyl]-1-(2H-tetrazol-5-yl)ethyl]hexan-2-one;(3S)-3-[(1S)-2-[6-[2-(dimethylamino)pyrimidin-5-yl]-3-pyridinyl]-1-(2H-tetrazol-5-yl)ethyl]hexan-2-one;(3S)-3-[(1S)-2-[5-[4-(3-hydroxyazetidin-3-yl)phenyl]-2-pyridinyl]-1-(2H-tetrazol-5-yl)ethyl]hexan-2-one;(3S)-3-[(1S)-2-[5-(1H-indazol-5-yl)-2-pyridinyl]-1-(2H-tetrazol-5-yl)ethyl]hexan-2-one;(3S)-3-[(1S)-2-[5-(1,2,3,6-tetrahydropyridin-4-yl)-2-pyridinyl]-1-(2H-tetrazol-5-yl)ethyl]hexan-2-one |
|---|---|
| PubChem CID | 158431567 |
| Molecular Formula | C120H150N40O7 |
| Molecular Weight | 2264.79 g/mol |
| Exact Mass | 2263.26 |
| IUPAC Name | (3S)-3-[(1S)-2-[5-(6-amino-3-pyridinyl)-2-pyridinyl]-1-(2H-tetrazol-5-yl)ethyl]hexan-2-one;(3S)-3-[(1S)-2-[6-(2,5-dihydro-1H-pyrrol-3-yl)-3-pyridinyl]-1-(2H-tetrazol-5-yl)ethyl]hexan-2-one;(3S)-3-[(1S)-2-[6-[2-(dimethylamino)pyrimidin-5-yl]-3-pyridinyl]-1-(2H-tetrazol-5-yl)ethyl]hexan-2-one;(3S)-3-[(1S)-2-[5-[4-(3-hydroxyazetidin-3-yl)phenyl]-2-pyridinyl]-1-(2H-tetrazol-5-yl)ethyl]hexan-2-one;(3S)-3-[(1S)-2-[5-(1H-indazol-5-yl)-2-pyridinyl]-1-(2H-tetrazol-5-yl)ethyl]hexan-2-one;(3S)-3-[(1S)-2-[5-(1,2,3,6-tetrahydropyridin-4-yl)-2-pyridinyl]-1-(2H-tetrazol-5-yl)ethyl]hexan-2-one |
| SMILES | CCCC(C(C)=O)[C@H](Cc1ccc(-c2ccc(C3(O)CNC3)cc2)cn1)c1nn[nH]n1.CCC[C@H](C(C)=O)[C@H](Cc1ccc(-c2ccc(N)nc2)cn1)c1nn[nH]n1.CCC[C@H](C(C)=O)[C@H](Cc1ccc(-c2ccc3[nH]ncc3c2)cn1)c1nn[nH]n1.CCC[C@H](C(C)=O)[C@H](Cc1ccc(-c2cnc(N(C)C)nc2)nc1)c1nn[nH]n1.CCC[C@H](C(C)=O)[C@H](Cc1ccc(C2=CCNC2)nc1)c1nn[nH]n1.CCC[C@H](C(C)=O)[C@H](Cc1ccc(C2=CCNCC2)cn1)c1nn[nH]n1 |
| InChI | InChI=1S/C23H28N6O2.C21H23N7O.C20H26N8O.C19H23N7O.C19H26N6O.C18H24N6O/c1-3-4-20(15(2)30)21(22-26-28-29-27-22)11-19-10-7-17(12-25-19)16-5-8-18(9-6-16)23(31)13-24-14-23;1-3-4-18(13(2)29)19(21-25-27-28-26-21)10-17-7-5-15(11-22-17)14-6-8-20-16(9-14)12-23-24-20;1-5-6-16(13(2)29)17(19-24-26-27-25-19)9-14-7-8-18(21-10-14)15-11-22-20(23-12-15)28(3)4;1-3-4-16(12(2)27)17(19-23-25-26-24-19)9-15-7-5-13(10-21-15)14-6-8-18(20)22-11-14;1-3-4-17(13(2)26)18(19-22-24-25-23-19)11-16-6-5-15(12-21-16)14-7-9-20-10-8-14;1-3-4-15(12(2)25)16(18-21-23-24-22-18)9-13-5-6-17(20-10-13)14-7-8-19-11-14/h5-10,12,20-21,24,31H,3-4,11,13-14H2,1-2H3,(H,26,27,28,29);5-9,11-12,18-19H,3-4,10H2,1-2H3,(H,23,24)(H,25,26,27,28);7-8,10-12,16-17H,5-6,9H2,1-4H3,(H,24,25,26,27);5-8,10-11,16-17H,3-4,9H2,1-2H3,(H2,20,22)(H,23,24,25,26);5-7,12,17-18,20H,3-4,8-11H2,1-2H3,(H,22,23,24,25);5-7,10,15-16,19H,3-4,8-9,11H2,1-2H3,(H,21,22,23,24)/t20?,21-;18-,19+;2*16-,17+;17-,18+;15-,16+/m011111/s1 |
| InChIKey | HBSILLUEWWXJRD-LTHINCAZSA-N |
| XLogP | 15.09 |
| TPSA | 659.45 Ų |
| H-Bond Donors | 12 |
| H-Bond Acceptors | 40 |
| Rotatable Bonds | 50 |
| Heavy Atoms | 167 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2264.79 |
| LogP ≤ 5 | 15.09 |
| H-Bond Donors ≤ 5 | 12 |
| H-Bond Acceptors ≤ 10 | 40 |